STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about CCNE
Insiders, 180 days
+$28.3K net bought
1 buyer · 2 sellers · 0% of sales under a 10b5-1 plan
CNB Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, CNB FINANCIAL CORP/PA insiders bought a net $28.3K of stock across 122 Form 4 purchases and sales, with 1 insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
22 earlier Form 4 trades (code P or S) here by this insider (22 buys), the last on Apr 24, 2026.
+0.2% median (+1.3% mean) 90-day return after 16 previous buys.
The trade is 1.9% of the 56,418 shares held after it.
No other insider bought within 30 days.
Insider activity: President & CEO Peduzzi Michael D bought about $38.9K of CCNE on Aug 5, 2026, the largest insider purchase at the company since 2023.
21 earlier Form 4 trades (code P or S) here by this insider (21 buys), the last on Jan 30, 2026.
-0.2% median (+0.5% mean) 90-day return after 15 previous buys.
The trade is 1.8% of the 55,318 shares held after it.
No other insider bought within 30 days.
Insider activity: President & CEO Peduzzi Michael D bought about $30.4K of CCNE on Apr 24, 2026, the largest insider purchase at the company since 2023.
122 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM CCNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM CCNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$85.7M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM CCNE
FY Dec 2025
$58.7M
FY Dec 2024
$55.2M
FY Dec 2023
$36.2M
FY Dec 2022
$51.8M
FY Dec 2021
$52.4M
Jun 2026
$36.0M
Mar 2026
$18.8M
Dec 2025
$26.0M
Sep 2025
$4.9M
Jun 2025
$17.9M
Mar 2025
$9.9M
Dec 2024
$18.8M
Sep 2024
$22.2M
At each fiscal year end
Single quarter
Debt to equity
0.22x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity CCNE
FY Dec 2025
0.29x
FY Dec 2024
0.14x
FY Dec 2023
0.15x
FY Dec 2022
0.41x
FY Dec 2021
0.19x
Jun 2026
0.22x
Mar 2026
0.28x
Dec 2025
0.29x
Sep 2025
0.32x
Jun 2025
0.13x
Mar 2025
0.14x
Dec 2024
0.14x
Sep 2024
0.14x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.45x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt CCNE
FY Dec 2025
0.26x
FY Dec 2024
0.85x
FY Dec 2023
0.56x
FY Dec 2022
0.30x
FY Dec 2021
0.70x
Jun 2026
0.45x
Mar 2026
0.29x
Dec 2025
0.26x
Sep 2025
0.23x
Jun 2025
0.95x
Mar 2025
0.83x
Dec 2024
0.85x
Sep 2024
0.79x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+12.4%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity CCNE
FY Dec 2025
+8.9%
FY Dec 2024
+9.2%
FY Dec 2023
+10.5%
FY Dec 2022
+13.0%
FY Dec 2021
+13.4%
Jun 2026
+12.4%
Mar 2026
+10.8%
Dec 2025
+8.9%
Sep 2025
+8.3%
Jun 2025
+8.9%
Mar 2025
+8.9%
Dec 2024
+9.2%
Sep 2024
+9.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+1.3%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets CCNE
FY Dec 2025
+0.9%
FY Dec 2024
+0.9%
FY Dec 2023
+1.0%
FY Dec 2022
+1.2%
FY Dec 2021
+1.1%
Jun 2026
+1.3%
Mar 2026
+1.1%
Dec 2025
+0.9%
Sep 2025
+0.8%
Jun 2025
+0.9%
Mar 2025
+0.9%
Dec 2024
+0.9%
Sep 2024
+0.9%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital CCNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed CCNE
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
11.26x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing CCNE
FY Dec 2025
10.64x
FY Dec 2024
10.45x
FY Dec 2023
8.86x
FY Dec 2022
7.30x
FY Dec 2021
8.39x
Jun 2026
10.74x
Mar 2026
10.20x
Dec 2025
10.64x
Sep 2025
9.84x
Jun 2025
9.61x
Mar 2025
9.55x
Dec 2024
10.45x
Sep 2024
10.33x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$787.7M
market value at close 2026-10-23 on 2026-08-05 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value CCNE
FY Dec 2025
$492.4M
FY Dec 2024
$163.4M
FY Dec 2023
$334.3M
FY Dec 2022
$612.5M
FY Dec 2021
-$200.9M
Jun 2026
$739.4M
Mar 2026
$504.7M
Dec 2025
$492.4M
Sep 2025
$541.6M
Jun 2025
$138.9M
Mar 2025
$31.3M
Dec 2024
$163.4M
Sep 2024
$228.8M
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+8.2%
TTM free cash flow over market value at close 2026-10-23
FCF yield CCNE
FY Dec 2025
+7.6%
FY Dec 2024
+10.6%
FY Dec 2023
+7.7%
FY Dec 2022
+10.3%
FY Dec 2021
+11.7%
Jun 2026
+8.6%
Mar 2026
+7.9%
Dec 2025
+7.6%
Sep 2025
+7.2%
Jun 2025
+14.3%
Mar 2025
+11.8%
Dec 2024
+10.6%
Sep 2024
+10.3%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.35x
P/E over trailing EPS growth of 32%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing CCNE
FY Dec 2025
3.16x
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
2.31x
FY Dec 2021
0.14x
Jun 2026
0.34x
Mar 2026
0.47x
Dec 2025
3.16x
Sep 2025
1.76x
Jun 2025
3.71x
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
CCNE ranks highest on profitability (71st percentile) and insider conviction (60th), and lowest on risk and compliance (50th), among Banks peers.
Profitability
71
Inputs
Return on equity+12.4% · 71 pct, sector of 327
Return on assets+1.3% · 71 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Financial health
52
Inputs
Debt to equity0.22x · 52 pct, sector of 229
Cash flow to debt0.45x · 53 pct, sector of 198
Insider conviction
60
Inputs
Net Form 4 buying (codes P and S), 180d$28K · 74 pct, sector of 274
Insider buyers, 180d1 · 46 pct, sector of 274
Risk and compliance
50
Inputs
Short interest, % of float+3.2% · 50 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Growth, Institutional and government, US patents
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Institutional and government needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
CCNE filings, in plain words
Are CNB Financial insiders buying or selling CCNE?
In the 180 days to 2026-10-27, CNB Financial insiders were net buyers, a net $28.3K: $38.9K of purchases and $10.6K of sales reported on Form 4, by 1 buyer and 2 sellers.
Read the full summary
In the 180 days to 2026-10-27, CNB Financial insiders were net buyers of CCNE, a net $28.3K across purchases and sales reported on Form 4 by 1 buyer and 2 sellers. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.